These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 30917102)
1. Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells. Miethe C; Zamora M; Torres L; Raign KG; Groll CJ; Price RS Horm Mol Biol Clin Investig; 2019 Mar; 38(2):. PubMed ID: 30917102 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of PI3K/Akt and ERK signaling decreases visfatin-induced invasion in liver cancer cells. Miethe C; Torres L; Zamora M; Price RS Horm Mol Biol Clin Investig; 2021 Aug; 42(4):357-366. PubMed ID: 34449178 [TBL] [Abstract][Full Text] [Related]
3. The role of visfatin and resistin in an in vitro model of obesity-induced invasive liver cancer. Miethe C; Torres L; Beristain J; Zamora M; Price RS Can J Physiol Pharmacol; 2021 Sep; 99(9):839-846. PubMed ID: 33356858 [TBL] [Abstract][Full Text] [Related]
4. The differential role of resistin on invasive liver cancer cells. Miethe C; Raign K; Zamora M; Price RS Horm Mol Biol Clin Investig; 2023 Sep; 44(3):285-293. PubMed ID: 36867542 [TBL] [Abstract][Full Text] [Related]
5. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells. Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585 [TBL] [Abstract][Full Text] [Related]
6. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Adya R; Tan BK; Punn A; Chen J; Randeva HS Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986 [TBL] [Abstract][Full Text] [Related]
7. Visfatin Promotes Monocyte Adhesion by Upregulating ICAM-1 and VCAM-1 Expression in Endothelial Cells via Activation of p38-PI3K-Akt Signaling and Subsequent ROS Production and IKK/NF-κB Activation. Lin YT; Chen LK; Jian DY; Hsu TC; Huang WC; Kuan TT; Wu SY; Kwok CF; Ho LT; Juan CC Cell Physiol Biochem; 2019; 52(6):1398-1411. PubMed ID: 31075190 [TBL] [Abstract][Full Text] [Related]
8. A Complex Relationship between Visfatin and Resistin and microRNA: An In Vitro Study on Human Chondrocyte Cultures. Cheleschi S; Giordano N; Volpi N; Tenti S; Gallo I; Di Meglio M; Giannotti S; Fioravanti A Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563239 [TBL] [Abstract][Full Text] [Related]
9. Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer. Miethe C; Nix H; Martin R; Hernandez AR; Price RS Nutr Cancer; 2017; 69(8):1272-1280. PubMed ID: 29068700 [TBL] [Abstract][Full Text] [Related]
10. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways. Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926 [TBL] [Abstract][Full Text] [Related]
11. Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential. Wang YY; Hung AC; Lo S; Yuan SF Cancer Lett; 2021 Feb; 498():229-239. PubMed ID: 33152400 [TBL] [Abstract][Full Text] [Related]
12. Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion. Elias-Miró M; Mendes-Braz M; Cereijo R; Villarroya F; Jiménez-Castro MB; Gracia-Sancho J; Guixé-Muntet S; Massip-Salcedo M; Domingo JC; Bermudo R; Rodés J; Peralta C J Hepatol; 2014 Jan; 60(1):87-95. PubMed ID: 23968888 [TBL] [Abstract][Full Text] [Related]
13. Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling. Ou HC; Lee WJ; Wu CM; Chen JF; Sheu WH J Vasc Surg; 2012 Apr; 55(4):1104-15. PubMed ID: 22244860 [TBL] [Abstract][Full Text] [Related]
14. Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells. Gholinejad Z; Kheiripour N; Nourbakhsh M; Ilbeigi D; Behroozfar K; Hesari Z; Golestani A; Shabani M; Einollahi N Peptides; 2017 Jun; 92():9-15. PubMed ID: 28442350 [TBL] [Abstract][Full Text] [Related]
15. Adiponectin and resistin protect steatotic livers undergoing transplantation. Jiménez-Castro MB; Casillas-Ramírez A; Mendes-Braz M; Massip-Salcedo M; Gracia-Sancho J; Elias-Miró M; Rodés J; Peralta C J Hepatol; 2013 Dec; 59(6):1208-14. PubMed ID: 23867317 [TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Effects of Resistin and Visfatin as Adipocyte Derived Hormones on Telomerase Gene Expression in AGS Gastric Cancer Cell Line. Mohammadi M; Zarghami N; Hedayati M; Ghaemmaghami S Acta Med Iran; 2017 Oct; 55(10):621-627. PubMed ID: 29228527 [TBL] [Abstract][Full Text] [Related]
18. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636 [TBL] [Abstract][Full Text] [Related]
19. Extracellular visfatin activates gluconeogenesis in HepG2 cells through the classical PKA/CREB-dependent pathway. Choi YJ; Choi SE; Ha ES; Kang Y; Han SJ; Kim DJ; Lee KW; Kim HJ Horm Metab Res; 2014 Apr; 46(4):233-9. PubMed ID: 24627100 [TBL] [Abstract][Full Text] [Related]
20. The role of heat shock protein 27 phosphorylation in the proliferation and apoptosis of human umbilical vein endothelial cells induced by Visfatin. Chen H; Lu N; Xu C; Zheng M Microvasc Res; 2019 Jan; 121():30-36. PubMed ID: 30145138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]